Your browser doesn't support javascript.
loading
Increased potency of recombinant VWF D'D3 albumin fusion proteins engineered for enhanced affinity for coagulation factor VIII.
Chia, Jenny; Pestel, Sabine; Glauser, Isabelle; Emmrich, Kerstin; Hardy, Matthew P; Mischnik, Marcel; Raquet, Elmar; Tomasetig, Vesna; Claar, Philipp; Zalewski, Anton; Bass, Gregory T; Turnbull, Victor; Chen, Chao-Guang; Wilson, Michael J; Panousis, Con; Weimer, Thomas; Andrews, Arna; Verhagen, Anne M; Dower, Steve K.
Afiliação
  • Chia J; CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia.
  • Pestel S; CSL Behring GmbH, Marburg, Germany.
  • Glauser I; CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia.
  • Emmrich K; CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia.
  • Hardy MP; CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia.
  • Mischnik M; CSL Behring GmbH, Marburg, Germany.
  • Raquet E; CSL Behring GmbH, Marburg, Germany.
  • Tomasetig V; CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia.
  • Claar P; CSL Behring GmbH, Marburg, Germany.
  • Zalewski A; CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia.
  • Bass GT; CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia.
  • Turnbull V; CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia.
  • Chen CG; CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia.
  • Wilson MJ; CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia.
  • Panousis C; CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia.
  • Weimer T; CSL Behring GmbH, Marburg, Germany.
  • Andrews A; CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia.
  • Verhagen AM; CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia.
  • Dower SK; CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia.
J Thromb Haemost ; 19(11): 2710-2725, 2021 11.
Article em En | MEDLINE | ID: mdl-34333849

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator VIII / Hemofilia A Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: J Thromb Haemost Assunto da revista: HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator VIII / Hemofilia A Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: J Thromb Haemost Assunto da revista: HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália